Latest Lupus erythematosus Stories
Lupus puts children at higher risk for coronary artery disease when they become adults, but routinely using statins doesn't provide enough benefit to warrant their regular use in children and adolescents.
WALTHAM, Mass., Aug.
HAYWARD, Calif., July 29 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc.
Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects DALLAS, July 12 /PRNewswire-USNewswire/ -- Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today.
ATLANTA, June 16 /PRNewswire-FirstCall/ -- UCB (Euronext: UCB) and Immunomedics, Inc. (Nasdaq: IMMU) announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE).
HAYWARD, Calif., June 10 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing therapeutics to treat serious diseases associated with inflammation and autoimmune disorders, today announced it has updated its Lupus Scientific Advisory Board.
WALTHAM, Mass., Feb.
Largest US study to date finds mortality outcomes improving.
New report resulting from Lupus Research Institute's congressional advocacy describes state of lupus research, impact of disease, and barriers to care NEW YORK, Jan. 22 /PRNewswire-USNewswire/ -- A major report on lupus from the Secretary of Health and Human Services to the U.S.
Contrary to previous studies, lupus patients who receive kidney transplants rarely develop lupus nephritis.